Der blev foretaget yderligere to undersøgelser af i alt 35 patienter med hjernesvulster for at vise, at kapslerne og infusionsopløsningen resulterer i den samme mængde temozolomid i blodet.
A further two studies were carried out in a total of 35 patients with brain tumours to show that the capsules and solution for infusion produce the same levels of temozolomide in the blood.